Colon cancer cells escape 5FU chemotherapy-induced ...
Type de document :
Article dans une revue scientifique
PMID :
URL permanente :
Titre :
Colon cancer cells escape 5FU chemotherapy-induced cell death by entering stemness and quiescence associated with the c-Yes/YAP axis
Auteur(s) :
Touil, Yasmine [Auteur]
Site de Recherche Intégrée en Cancérologie [SIRIC-ONCOLille]
Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer - U837 [JPArc]
Igoudjil, Wassila [Auteur]
Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer - U837 [JPArc]
Corvaisier, Matthieu [Auteur]
Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer - U837 [JPArc]
Dessein, Anne-Frédérique [Auteur]
Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer - U837 [JPArc]
Vandomme, Jerome [Auteur]
Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer - U837 [JPArc]
Monte, Didier [Auteur]
Institut de Recherche Interdisciplinaire [Villeneuve d'Ascq] [IRI]
Stechly, Laurence [Auteur]
Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer - U837 [JPArc]
Skrypek, Nicolas [Auteur]
Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer - U837 [JPArc]
Langlois, Carole [Auteur]
Unité de biostatistiques
Grard, Georges [Auteur]
Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer - U837 [JPArc]
Millet, Guillaume [Auteur]
Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer - U837 [JPArc]
Département de Chirurgie Digestive B et Transplantation [Hôpital Saint-Eloi - CHU Montpellier]
Leteurtre, Emmanuelle [Auteur]
Dumont, Patrick [Auteur]
Institut de biologie de Lille - IBL [IBLI]
Truant, Stéphanie [Auteur]
Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer - U837 [JPArc]
Département de Chirurgie Digestive B et Transplantation [Hôpital Saint-Eloi - CHU Montpellier]
Pruvot, Francois-Rene [Auteur]
Département de Chirurgie Digestive B et Transplantation [Hôpital Saint-Eloi - CHU Montpellier]
Hebbar, Mohamed [Auteur]
Service d'oncologie médicale
Fan, Fan [Auteur]
The University of Texas M.D. Anderson Cancer Center [Houston]
Ellis, Lee M. [Auteur]
The University of Texas M.D. Anderson Cancer Center [Houston]
Formstecher, Pierre [Auteur]
Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer - U837 [JPArc]
VAN SEUNINGEN, ISABELLE [Auteur]
Gespach, Christian [Auteur]
Polakowska, Renata [Auteur]
Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer - U837 [JPArc]
Huet, Guillemette [Auteur]
Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer - U837 [JPArc]
Site de Recherche Intégrée en Cancérologie [SIRIC-ONCOLille]
Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer - U837 [JPArc]
Igoudjil, Wassila [Auteur]
Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer - U837 [JPArc]
Corvaisier, Matthieu [Auteur]
Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer - U837 [JPArc]
Dessein, Anne-Frédérique [Auteur]
Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer - U837 [JPArc]
Vandomme, Jerome [Auteur]

Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer - U837 [JPArc]
Monte, Didier [Auteur]

Institut de Recherche Interdisciplinaire [Villeneuve d'Ascq] [IRI]
Stechly, Laurence [Auteur]
Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer - U837 [JPArc]
Skrypek, Nicolas [Auteur]
Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer - U837 [JPArc]
Langlois, Carole [Auteur]
Unité de biostatistiques
Grard, Georges [Auteur]
Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer - U837 [JPArc]
Millet, Guillaume [Auteur]
Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer - U837 [JPArc]
Département de Chirurgie Digestive B et Transplantation [Hôpital Saint-Eloi - CHU Montpellier]
Leteurtre, Emmanuelle [Auteur]

Dumont, Patrick [Auteur]
Institut de biologie de Lille - IBL [IBLI]
Truant, Stéphanie [Auteur]

Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer - U837 [JPArc]
Département de Chirurgie Digestive B et Transplantation [Hôpital Saint-Eloi - CHU Montpellier]
Pruvot, Francois-Rene [Auteur]
Département de Chirurgie Digestive B et Transplantation [Hôpital Saint-Eloi - CHU Montpellier]
Hebbar, Mohamed [Auteur]
Service d'oncologie médicale
Fan, Fan [Auteur]
The University of Texas M.D. Anderson Cancer Center [Houston]
Ellis, Lee M. [Auteur]
The University of Texas M.D. Anderson Cancer Center [Houston]
Formstecher, Pierre [Auteur]
Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer - U837 [JPArc]
VAN SEUNINGEN, ISABELLE [Auteur]

Gespach, Christian [Auteur]
Polakowska, Renata [Auteur]
Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer - U837 [JPArc]
Huet, Guillemette [Auteur]
Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer - U837 [JPArc]
Titre de la revue :
Clinical cancer research
Nom court de la revue :
Clin. Cancer Res.
Numéro :
20
Pagination :
837-846
Date de publication :
2014-02-15
ISSN :
1078-0432
Mot(s)-clé(s) en anglais :
Gene Expression
Cell Proliferation
Humans
Kaplan-Meier Estimate
Proportional Hazards Models
Drug Resistance, Neoplasm
Neoplastic Stem Cells
Liver Neoplasms
Biomarkers, Tumor
Nuclear Proteins
Protein Transport
HT29 Cells
Disease-Free Survival
Cell Cycle Checkpoints
Neoplasm Micrometastasis
Proto-Oncogene Proteins c-yes
Checkpoint Kinase 2
Antimetabolites, Antineoplastic
Neoadjuvant Therapy
Transcription Factors
Chemotherapy, Adjuvant
Cell Nucleus
Colonic Neoplasms
Fluorouracil
Cell Proliferation
Humans
Kaplan-Meier Estimate
Proportional Hazards Models
Drug Resistance, Neoplasm
Neoplastic Stem Cells
Liver Neoplasms
Biomarkers, Tumor
Nuclear Proteins
Protein Transport
HT29 Cells
Disease-Free Survival
Cell Cycle Checkpoints
Neoplasm Micrometastasis
Proto-Oncogene Proteins c-yes
Checkpoint Kinase 2
Antimetabolites, Antineoplastic
Neoadjuvant Therapy
Transcription Factors
Chemotherapy, Adjuvant
Cell Nucleus
Colonic Neoplasms
Fluorouracil
Discipline(s) HAL :
Chimie/Chimie théorique et/ou physique
Résumé en anglais : [en]
PURPOSE: Metastasis and drug resistance are the major limitations in the survival and management of patients with cancer. This study aimed to identify the mechanisms underlying HT29 colon cancer cell chemoresistance acquired ...
Lire la suite >PURPOSE: Metastasis and drug resistance are the major limitations in the survival and management of patients with cancer. This study aimed to identify the mechanisms underlying HT29 colon cancer cell chemoresistance acquired after sequential exposure to 5-fluorouracil (5FU), a classical anticancer drug for treatment of epithelial solid tumors. We examined its clinical relevance in a cohort of patients with colon cancer with liver metastases after 5FU-based neoadjuvant chemotherapy and surgery. RESULTS: We show that a clonal 5F31 cell population, resistant to 1 μmol/L 5FU, express a typical cancer stem cell-like phenotype and enter into a reversible quiescent G0 state upon reexposure to higher 5FU concentrations. These quiescent cells overexpressed the tyrosine kinase c-Yes that became activated and membrane-associated upon 5FU exposure. This enhanced signaling pathway induced the dissociation of the Yes/YAP (Yes-associated protein) molecular complex and depleted nuclear YAP levels. Consistently, YES1 silencing decreased nuclear YAP accumulation and induced cellular quiescence in 5F31 cells cultured in 5FU-free medium. Importantly, YES1 and YAP transcript levels were higher in liver metastases of patients with colon cancer after 5FU-based neoadjuvant chemotherapy. Moreover, the YES1 and YAP transcript levels positively correlated with colon cancer relapse and shorter patient survival (P < 0.05 and P < 0.025, respectively). CONCLUSIONS: We identified c-Yes and YAP as potential molecular targets to eradicate quiescent cancer cells and dormant micrometastases during 5FU chemotherapy and resistance and as predictive survival markers for colon cancer.Lire moins >
Lire la suite >PURPOSE: Metastasis and drug resistance are the major limitations in the survival and management of patients with cancer. This study aimed to identify the mechanisms underlying HT29 colon cancer cell chemoresistance acquired after sequential exposure to 5-fluorouracil (5FU), a classical anticancer drug for treatment of epithelial solid tumors. We examined its clinical relevance in a cohort of patients with colon cancer with liver metastases after 5FU-based neoadjuvant chemotherapy and surgery. RESULTS: We show that a clonal 5F31 cell population, resistant to 1 μmol/L 5FU, express a typical cancer stem cell-like phenotype and enter into a reversible quiescent G0 state upon reexposure to higher 5FU concentrations. These quiescent cells overexpressed the tyrosine kinase c-Yes that became activated and membrane-associated upon 5FU exposure. This enhanced signaling pathway induced the dissociation of the Yes/YAP (Yes-associated protein) molecular complex and depleted nuclear YAP levels. Consistently, YES1 silencing decreased nuclear YAP accumulation and induced cellular quiescence in 5F31 cells cultured in 5FU-free medium. Importantly, YES1 and YAP transcript levels were higher in liver metastases of patients with colon cancer after 5FU-based neoadjuvant chemotherapy. Moreover, the YES1 and YAP transcript levels positively correlated with colon cancer relapse and shorter patient survival (P < 0.05 and P < 0.025, respectively). CONCLUSIONS: We identified c-Yes and YAP as potential molecular targets to eradicate quiescent cancer cells and dormant micrometastases during 5FU chemotherapy and resistance and as predictive survival markers for colon cancer.Lire moins >
Langue :
Anglais
Audience :
Non spécifiée
Établissement(s) :
CHU Lille
CNRS
Inserm
Université de Lille
CNRS
Inserm
Université de Lille
Collections :
Équipe(s) de recherche :
Biologie structurale et intégrative
Date de dépôt :
2020-02-12T15:11:29Z
2021-03-11T13:16:17Z
2021-06-15T12:12:51Z
2021-03-11T13:16:17Z
2021-06-15T12:12:51Z